Study of OSE-127 vs Placebo in Patients With Moderate to Severe Active Ulcerative Colitis

NCT04882007 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

136

Enrollment

INDUSTRY

Sponsor class

Conditions

Ulcerative Colitis

Interventions

DRUG: OSE-127
DRUG: Placebo

Sponsor

OSE Immunotherapeutics